Abstract -Withdrawal hyperexcitability was seen in isolated mouse hippocampal slices, prepared after chronic treatment with ethanol, by inhalation for 2 weeks. The pattern of hyperexcitability differed from those seen previously when a different method of ethanol administration and a different strain of mice were used. Thresholds for field potentials were decreased, but the transient increase in paired pulse potentiation, reported earlier, was not evident. Chronic administration of the calcium channel antagonist, isradipine (PN-200-110) during ethanol treatment significantly decreased the withdrawal syndrome, both in vivo and in vitro. Brain concentrations of isradipine during the test period were found to be sufficient to produce acute effects on the withdrawal hyperexcitability. No changes were seen in the field potentials when slices were prepared after treatment with isradipine alone. A small, but significant, increase in excitability was seen in vivo after the treatment with isradipine alone. Previous studies showed that isradipine did not protect against the hyperexcitability due to gamma-aminobutyric acid (GABA) A antagonism, so the results suggest that neuronal calcium channels may be involved in ethanol withdrawal hyperexcitability, but decreases in GABA A inhibition may not be important.
INTRODUCTION
Chronic intake of ethanol causes tolerance and physical dependence, but the mechanisms involved are not well understood. The ethanol withdrawal syndrome in animals was first quantified by Goldstein and Pal (1971) . It is measured by the occurrence of signs such as tremor, hyperreflexia and convulsions. In humans, similar symptoms occur, accompanied by confusional states and hallucinations. Drugs such as the benzodiazepines or barbiturates will substitute for ethanol in withdrawal, but these compounds possess dependence liability of their own and do not appear to alter the underlying changes responsible for ethanol dependence.
Recent evidence suggests that neuronal calcium channels play an important role in ethanol dependence. Acutely, ethanol decreases calcium conductance. Harris and Hood (1980) found that high concentrations (50-800 mM) of ethanol decreased potassium-stimulated calcium uptake by brain synaptosomes. Leslie et al. (1983) showed that when short incubation times (1-60 s) were used, ethanol decreased depolarization-dependent calcium uptake by rat brain synaptosomes, and that this effect was lost after chronic ethanol treatment. Alcohols have been shown to have a blocking action on the 'T'-subtype of channel (Llinas, 1988) . Llinas and Yarom (1986) found octanol to be the most effective at blocking this low threshold current, but ethanol showed this action at concentrations (100 /JM and 1 mM) that are in the lowest range for production of behavioural changes.
Chronic administration of ethanol in vivo increases the number of dihydropyridine binding sites in the central nervous system (Dolin et al, 1987) . This increase was accompanied by increases in the actions of the dihydropyridines on transmitter release and on inositol phospholipid breakdown, suggesting a functional change caused by ethanol. These sites are thought to represent voltage-sensitive calcium channels. Dihydropyridines are selective for one subtype of calcium channel, described as the 'L'-subtype (Nowycky et al, 1985) . In strains of rodents inbred for either ethanol withdrawal sensitivity or resistance, the increase in dihydropyridine binding sites after ethanol treatment correlated with withdrawal severity (Brennan et al, 1990) . Dihydropyridine calcium channel antagonists have few overt behavioural actions in normal circumstances.
They were originally thought to have little effect on neurones, but actions on central neurones have now been reported (Middlemiss and Spedding, 1985; Raeburn and Gonzales, 1988; Grover and Teyler, 1990) .
Calcium channel antagonists, such as nitrendipine and nimodipine, given acutely at the start of ethanol withdrawal, decrease the ethanol withdrawal syndrome . The dihydropyridine isradipine showed stereospecificity in parallel with that seen on calcium channels in vitro (Hof et al, 1985) . The effect of the dihydropyridines was selective for the ethanol withdrawal syndrome, as these compounds had little anticonvulsant action in other convulsive states (Dolin etai, 1988) . We have found no anticonvulsant action against the gammaaminobutyric acid (GABA) A antagonist bicuculline (Dolin et al., 1988) . When administered acutely with ethanol, dihydropyridine calcium channel antagonists potentiated the pharmacological actions of ethanol .
In addition to these acute actions, we have found that these calcium channel antagonists can modulate the development of physical dependence on ethanol. Nitrendipine and nifedipine, when given chronically with ethanol, prevented the development of tolerance to ethanol (Wu et al, 1987; Dolin and Little, 1989) . We showed that insufficient nitrendipine was present in the brains at the time of testing to have an acute action. It was suggested that the calcium channel antagonist prevented the development of the changes responsible for tolerance by inhibiting the increase in dihydropyridinesensitive calcium channels caused by ethanol treatment, as chronic dihydropyridine treatment has been found to cause down-regulation of the binding sites (Panza etal, 1985) . This hypothesis was supported when we showed that nitrendipine, given chronically, prevented the ethanol withdrawal syndrome in vivo and in vitro (Whittington and Little, 1991a; Whittington etal, 1991) . In these studies, 24 or 48 h time intervals were allowed for nitrendipine to be removed from the CNS, between the end of the dihydropyridine administration and the withdrawal testing. Measurements of brain nitrendipine concentrations showed that these were too low at the times that the withdrawal syndrome was measured for the results to have been due to acute actions of the residual drag. In each of these studies, the increase in dihydropyridine binding caused by ethanol treatment was prevented by the dihydropyridine administration. Such prevention of adaptive responses by a drug given during the ethanol intake period had not previously been demonstrated with any type of compound.
The aims of the present study were twofold. The first was to determine whether or not the unusual action of nitrendipine in modifying the adaptive responses to ethanol could be reproduced if the mouse strain, the methods of ethanol and dihydropyridine administration and the particular dihydropyridine used, were all altered. Ethanol was therefore given chronically by inhalation to mice of the TO strain (our previous studies used the C57 strain with ethanol given via the drinking fluid). Both behavioural manifestations of withdrawal and the electrophysiological changes in isolated hippocampal slices were measured at the end of the chronic ethanol and dihydropyridine treatments. Secondly, we wished to investigate the effects of chronic administration of another dihydropyridine antagonist, isradipine, in behavioural and electrophysiological experiments. In our earlier studies, it was not possible to investigate the effects of chronic treatment with nitrendipine alone, because the compound was given via the drinking fluid and was too insoluble to dissolve in water in the absence of ethanol. In the present study, therefore, we have examined the effects of chronic administration of isradipine, given by the intraperitoneal (i.p.) route. Brain concentrations of the dihydropyridine were measured at the time of withdrawal testing, to determine whether the residual compound could have had any acute action, or if the effects were due solely to responses to the chronic treatment.
MATERIALS AND METHODS

Chronic drug administration
Male mice of the TO strain (25-30 g) were kept in inhalational chambers for 2 weeks in an atmosphere of 10-15 mg/1 of ethanol. The ethanol concentrations in the chambers were measured twice daily. Control animals were kept in the same environment, outside the inhalational chambers.
Racemic isradipine [isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-methoxy-carbonyl-pyridine-3-carboxylate] was suspended in Tween 80 (0.5%, w/v) and sonicated well before use. As the drug is photosensitive, it was protected from light at all times by use of a red safelight and dark bottles. Mice were given i.p. injections twice daily (at 10:00 and 22:00) of either isradipine, lOmg/kg, or the vehicle, Tween 80 (0.5%, w/v). The dose volume used was 10 ml/kg. Separate groups of mice were given isradipine, 10 mg/kg, or vehicle, twice daily, by i.p. injection, in the absence of ethanol. The body temperatures of mice given isradipine were maintained at 37 ± 0.5°C with wanning mats and overhead lights. All groups of animals remained healthy throughout the treatments. They were weighed at regular intervals during the treatments and there were no significant differences between the weight gains of the different groups.
The choice of dose of isradipine was based on our previous work . The last injections of isradipine were given 24 h before the withdrawal of ethanol, with the intention of avoiding the acute actions of the compound. This time interval was chosen on the basis of the effects of isradipine on locomotor activity and body temperature in this strain of mice. Our results have shown that these effects could be seen for only 1-2 h after i.p. injection of 10 mg/kg of isradipine . Although the duration of the acute effect on the ethanol withdrawal syndrome was greater than this, it was thought that this might be accounted for by the prevention of the initial stages of withdrawal hyperexcitability that might block the further development of the withdrawal syndrome.
Measurement of the ethanol withdrawal syndrome
The ethanol withdrawal syndrome was measured by ratings of convulsive behaviour on handling (Goldstein and Pal, 1971; Green et al, 1990) . This method measures both tremor and clonic convulsions, with a rating scale from 0 (no evidence of hyperexcitability) to 4 (full clonic convulsion). The incidence of tonic extensor spasms, when the mice were gently picked up by the tail, were rated separately. The mice were removed from the ethanol between 09:00 and 09:30. Behavioural ratings were made once an hour on all mice for 12 h. The observer who carried out the ratings was blind to the prior drug treatment. All the behavioural ratings, between 1 and 12 h from the start of withdrawal, were used for the statistical comparisons. The results were expressed as median values ± interquartile ranges. Each treatment group contained 13 mice.
The same method was used to examine the behaviour after chronic treatment with isradipine alone. In separate experiments, ratings of behaviour in response to handling were made hourly between 6 and 12 h, 12 and 24 h, 24 and 36 h and 36 and 48 h from the last isradipine injection. Each treatment group contained between 9 and 12 mice.
Electrophysiological recordings
Hippocampal slices were prepared between 09:30 and 10:30 each day. The animals were not withdrawn from the ethanol before preparation of the slices, so ethanol would have been gradually washed out of the slices during the beginning of the recording period. Dissections were made in HEPES medium (see below) and 400 /zm slices of hippocampus cut on a Mcllwain chopper. The slices were maintained in recording chambers on nylon mesh and lens tissue, superfused with Krebs' solution (see below) at 30 ± 0.5°C and 1.7 ml/min. Extracellular recordings from stratum pyramidale in area CA1 were started 45 min after the slices were placed in the perfusion bath, i.e. 75 min from removal of tissues.
Orthodromic stimulation of Schaffer collateral/ commissural fibres was given, using paired pulses, constant current, 50 fis duration and 0.1 Hz. The stimulating electrodes consisted of two silver insulated wires, 0.2 mm in diameter, passed through 1 mm diameter silicon tubing. Recording electrodes were made from 1.2 mm diameter electrode glass and filled with 2M KC1; the resistances were between 5 and 15 Mfl. Paired stimuli were given in order to study the phenomenon of paired pulse potentiation (the ability of the slice to respond to a rapidly repeating input). A 70 ms interval was used for the paired pulses, because preliminary experiments showed that it gave the maximum paired pulse potentiation in normal mouse hippocampal slices.
The thresholds for the elicitation of single population spikes and multiple population spikes, and paired pulse potentiation, were measured every 15 min. The single spike threshold was the minimum stimulating current required to produce a single population spike superimposed on the EPSP produced by the first of the paired stimuli, as discerned by eye. The threshold for multiple population spikes was the minimum stimulating current required to produce a second population spike, seen after the first but superimposed on the same EPSP. A stimulation level of 1.25 times the threshold stimulation for elicitation of a single population spike was used in the studies on paired pulse potentiation. Input/output curves were determined at 3, 5 and 7 h from removal of tissues, i.e. from the start of ethanol withdrawal, using fourteen stimulation levels in the range 14-145 /zA. The areas of the population spikes were measured by Acorn computer analysis. In every case a minimum of three responses were averaged for each stimulus.
Care was taken to ensure that the placing of the stimulating and recording electrodes was consistent, to allow valid comparisons between slices prepared from animals of different treatment groups . The order of testing and the distribution of the various treatments between the two recording chambers were carefully balanced for the different drug treatment groups. Slices were rejected only if the threshold for elicitation of single population spikes was over 100/iA or if the maximum spike amplitude was <4 mV.
Five or six tissues, all from different animals, were used for each treatment group. The results were expressed as mean ± SEM for each of the treatments. The times given in the Results section are all from the removal of the tissues. This corresponded to the withdrawal of ethanol.
At the completion of each day's experiments the perfusion chamber was washed through with distilled water for at least 30 min, and additionally washed through every 5 days with 500 mM sodium hydroxide followed by 100 mM citric acid.
Statistical analysis
The ratings of the withdrawal syndrome, and the measurements of multiple population spike thresholds, were compared by non-parametric analysis of variance, using a format designed for repeat measurements on the same samples and multiple comparisons with controls (Meddis, 1984) . A corresponding two-way parametric analysis was used for the thresholds for elicitation of single population spike and for measurements of paired pulse potentiation.
Input/output relationships were derived from population spike area, and EPSP slope data. Nonlinear regression was used to produce sigmoidal curves, to enable calculation of the stimulus required to produce half-maximal responses and the maximal responses obtained. Comparisons of data from these curves were made between different tissues, following the various treatments, using Student's unpaired /-test. The incidences of tonic extensor spasms were compared by Fisher's exact probability test.
Composition of solutions
The composition of the perfusion fluid was (mM): NaCl 124, KC1 3.25, NaH 2 PO 4 1.25, NaHCO 3 20.0, MgSO 4 2.0, CaCl 2 2.0, and r> glucose 10.0. The pH was 7.2 at 30°C. The composition of the HEPES-buffered dissection medium was (mM): NaCl 120, KC1 2.0, KH 2 PO 4 1.25, NaHCO 3 20.0, MgSO 4 2.0, CaCl 2 2.0, r> glucose 10.0, HEPES acid 7.0 and Na-HEPES 2.6. The pH was 7.2 at 23°C.
Measurement of central isradipine concentrations
Measurements were made of the concentrations of isradipine in brains removed from animals receiving chronic treatment. The brains were removed, following cervical dislocation, from mice that had been given injections of isradipine for 2 weeks as described above, either with or without concurrent ethanol treatment. Tissues were taken 32 h after the last injection, i.e. 8 h after withdrawal of ethanol, to correspond with the peak drug effect in the withdrawal testing. Comparison was made with the brain concentrations 2 and 6 h after acute injections of isradipine given to naive animals. Whole brain isradipine concentrations were measured by gas-liquid chromatography. Electron capture detection was used to analyse samples separated with a 25 m capillary column coated with SE30. The temperature programming for the analysis was as follows: injector 280°C, detector 320°C, oven started at 180°C for 2 min then ramped up to 290°C at 16°C/min and left at this temperature for 10 min. Helium carrier gas at 6 p.s.i. was used to ensure the flow of sample along the column at the optimum speed for separation. The sample was flushed from the end of the capillary column into the detector with nitrogen make-up gas at 20 p.s.i. •. (c) Ratings of convulsive behaviour on handling after 2 weeks chronic treatment with isradipine alone, compared with values for vehicle-injected controls. The last injections of isradipine were made 6 h before the testing began. The ratings after the isradipine treatment were significantly lower (P < 0.05) than the control values when comparison was made over the whole testing period. Values are medians with interquartile ranges. Controls: •; chronic isradipine: A-(d) Ratings of convulsive behaviour on handling after 2 weeks chronic treatment with isradipine alone, compared with values for vehicleinjected controls. The last injections of isradipine were made 24 h before the testing began. The ratings after the isradipine treatment were significantly higher (P < 0.05) than the control values when comparison was made over the whole testing period. Values are medians with interquartile ranges. Controls: fj; chronic isradipine: A-
The brains were homogenized in 10 M NaOH (lml per 50 mg wet weight) and protein was precipitated with sodium tungstate and sulphuric acid. The samples were centrifuged at 4000 rpm for lOmin, then the isradipine was extracted by shaking with the same volume of toluene. The organic layer was removed and dried with anhydrous MgSO 4 , then the samples evaporated to dryness and reconstituted in 100 /il toluene, with 1 /zM nimodipine as internal standard.
RESULTS
Behavioural measurements of withdrawal hyperexcitability
Chronic administration of isradipine completely prevented the behavioural hyperexcitability of the ethanol withdrawal syndrome (Fig. la and b) . The ratings of convulsive behaviour (Fig. la) were significantly lower (P < 0.001) when isradipine was given with ethanol. The ratings for the animals given ethanol plus isradipine were not significantly different from control values. Concurrent administration of isradipine with the ethanol also decreased the incidence of tonic extensor spasms during ethanol withdrawal (Fig.  lb) . This behaviour was not continuous with the tremor or clonic convulsions recorded by the rating scale, so was not included in our rating scale, but up to 60% of mice showed the behaviour following treatment with ethanol alone. No tonic extensor spasms were seen when isradipine was given with ethanol. Comparison of the incidence of tonic extensor spasms, in the groups receiving ethanol alone and ethanol plus isradipine, gave P = 0.005 at 8h, P < 0.02 at 9 and 10 h and P < 0.05 at 7, 11 and 12 h into the withdrawal period.
When isradipine was given for 2 weeks in the absence of ethanol, a decrease {P < 0.05) in the responses to handling was seen between 6 and 18 h after the last of the chronic treatment injections (Fig. lc) . There was no evidence of changes in behaviour in this test when ratings of behaviour were made from 12 to 24 h or from 36 to 48 h (data not shown). However, when measurements were made between 24 and 36 h from the last injections, there was a very small but significant (P < 0.05) increase in the ratings after isradipine treatment, compared with control values (Fig. Id) .
Electrophysiological recordings
Single population spike thresholds. Tissues prepared after chronic ethanol treatment showed a significant decrease in the threshold stimulation required to elicit a single population spike (P<0.01) between 2 and 7h from ethanol withdrawal (i.e. from preparation of tissues). When isradipine was given with ethanol, this decrease was not seen (Fig. 2a) . The mean values for the thresholds after chronic treatment with ethanol plus isradipine were not significantly higher than control values. Administration of isradipine alone for 2 weeks did not significantly alter the thresholds for elicitation of single population spikes (Fig. 2b) . Examples of the traces obtained in these studies are illustrated in a. Multiple population spike thresholds. Concurrent administration of isradipine also prevented the decrease in multiple population spike thresholds caused by ethanol withdrawal (Fig. 3a) . The values between 3.5 and 7 h from withdrawal were significantly lower after the ethanol treatment (/ > <0.01), compared with either control values or those obtained after treatment with ethanol plus isradipine. An example of the multiple population spikes is illustrated in Fig. 4b . The thresholds following treatment with isradipine plus ethanol or isradipine alone were not sig- nificantly different from control values. However, the measurements of these thresholds were limited by the maximum output of the stimulators and could not be measured over 230 pA. As a large proportion of the thresholds in the control, ethanoi plus isradipine and isradipine-alone groups were at this value, changes above this may have occurred that would not have been seen in the experiments. Paired pulse potentiation. Comparison of paired pulse potentiation over the whole of the withdrawal period showed no significant differences between any of the treatment groups (Fig. 5a, b) . However, inspection of Fig. 5a shows that there Fig. 4 . Examples of traces recorded 5.5 h after preparation of isolated hippocampal slices after chronic treatment in vivo with either ethanoi alone or ethanoi plus isradipine, compared with control. Multiple population spikes can be seen on the trace recorded from a hippocampal slice after chronic ethanoi treatment, while no secondary discharges occurred when isradipine was given with the ethanoi, or after isradipine alone. Stimulation was applied at the same level, 180/xA, in each set of traces, at the times indicated by the arrows, (a) Control trace; (b) chronic treatment with ethanoi alone; (c) chronic ethanoi plus isradipine; (d) chronic treatment with isradipine alone.
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was an initial peak in the paired pulse potentiation values at 1.5 and 1.75 h into withdrawal, not seen in the control values. This resembled the transient increase in paired pulse potentiation we found in previous studies after chronic administration of ethanol alone, when a different strain of mice and method of ethanol administration were used ). In our previous work, the increase was more pronounced and was maximal at 2.25 h into withdrawal. No increase was seen in the present study when isradipine was given with ethanol in the chronic treatment. No significant changes in paired pulse potentiation were seen after chronic treatment with isradipine alone (Fig. 5b ). An example of the paired pulse potentiation is illustrated in Fig. 4c . Input/output curves. No significant differences were found in the stimuli required to cause maximal responses or in the amplitude of the maximal responses when treatment with either ethanol alone or ethanol plus isradipine was compared with controls. Figure 6a shows these input/output curves, obtained at 5 h into withdrawal. Although the input/output curve after treatment with isradipine alone (Fig. 6b) showed a lower maximum than controls, the difference was not significant. Table 1 gives the central concentrations of isradipine, measured 8 h after ethanol withdrawal, that is 32 h after the last injection of isradipine. These have been compared with concentrations 597 ± 20 ng/g (6) 546 ± 10 ng/g (6) 334 ±81 ng/g (6) 293 ±51 ng/g (6) Values are means ± SEM for the number of mice indicated in parentheses. 'Brains taken 32 h after the last injections of isradipine, 8 h after cessation of ethanol treatment. ""Brains taken after acute administration in naive animals.
Brain concentrations of isradipine
observed at 2 and 6 h after an acute dose of isradipine, when the acute protective action of the compound could be seen (Littleton et ai, 1990) . It was apparent from these results that accumulation of isradipine occurred during the chronic treatment, and that, despite the 24 h washout interval, the concentrations in the CNS at the time of the behavioural testing were higher than those achieved after acute injection.
DISCUSSION
The results of this study showed that the patterns of hyperexcitability seen in the hippocampal slices were similar, but not identical, to those seen in our earlier studies Little, 1990, 1991a; Morton et ai, 1992) . A different strain of mice (TO rather than C57) and a different method of ethanol treatment (inhalation for 2 weeks rather than drinking fluid for 12-18 weeks) were used. In both our earlier work and the present study decreases in thresholds for elicitation of population spikes were seen. It did not appear that the extent of the present threshold changes differed from our previous results to an extent greater than the variation we have seen previously between groups of mice receiving the same treatment schedules.
The main differences found between this and our previous electrophysiological observations were in the paired pulse potentiation and input/ output curves. Paired pulse potentiation is a form of short-term plasticity, that indicated the ability of the preparation to respond to a rapidly repeating stimulus input. Previously, when C57 mice, drinking ethanol, were used, we saw a clear and consistent increase in paired pulse potentiation, reaching a maximum 2-2.5 h into withdrawal and disappearing by 4 h Little, 1990, 1991a; Morton et ai, 1992) . Although there was a small indication of an increase in the present study, the pattern was clearly different from that seen in our previous studies. In an earlier study, we reported that the increase in paired pulse potentiation was seen after short periods of ethanol drinking that were insufficient to cause behavioural excitability (Morton et ai, 1992) . In our earlier field potential recordings, we found some changes in the input/output curves, but unlike the threshold and paired pulse potentiation changes, these have not always been totally consistent Little, 1990, 1991a) .
We have measured GABA A inhibition in the hippocampal slice, after chronic treatment of C57 mice with ethanol via the drinking fluid (Whittington et ai, 1992a) . GABA A inhibition was increased at the time at which we previously saw the increase in paired pulse potentiation and this may have contributed to the change in this form of plasticity. The GABA A inhibition was not decreased at any time during the withdrawal period, suggesting that disinhibition does not contribute to the withdrawal hyperexcitability. We have also obtained evidence from intracellular studies that A/-methyl-D-aspartate (NMDA)-receptor-mediated transmission and the activity of voltage-operated calcium channels are increased towards the end of the 7 h recording period (Whittington et ai, 1992A,c) .
The behavioural excitability seen in the TO strain of mice when ethanol was given by inhalation closely resembled that seen in our previous work when ethanol was given to C57 mice via the drinking fluid (Green et ai, 1990; Whittington et ai, 1991) . This suggests that the changes in paired pulse potentiation seen in our earlier work were not of major importance in causing the behavioural syndrome and that the threshold changes may be more relevant. However, although the decrease in threshold for elicitation of single population spikes was seen near the beginning of the recording period, the decrease in multiple spike threshold did not appear until considerably later. The behavioural syndrome would occur later than the corresponding electrophysiological changes recorded in vitro, because residual ethanol would have washed rapidly out of the hippocampal slices during the first part of the recording period. The amount of ethanol taken in by each mouse immediately prior to study (i.e. during the night before each experiment) would have influenced previous results, but this problem did not arise in the present work, as the amount of ethanol inhaled was controlled externally.
The results also showed that when the calcium channel antagonist, isradipine, was given chronically with ethanol, both the behavioural and electrophysiological signs of hyperexcitability, normally seen on ethanol withdrawal, were abolished. Our previous work showed that isradipine stereoselectively protected against the ethanol withdrawal syndrome when given immediately on withdrawal from ethanol . It is likely that such an acute action was responsible for the effects seen in the behavioural studies in this paper, as the brain concentrations at the time of peak drug effect showed that accumulation of isradipine occurred during the chronic treatment. This result is in contrast to our earlier work, which showed that nitrendipine did not accumulate during our chronic treatment schedules and that the effects of repeated administration of nitrendipine were not due to its presence in the CNS at the times of testing (Dolin and Little, 1989; Whittington et al., 1991) .
No significant changes were seen in the electrophysiological experiments, when the slices were prepared 24 h after the last of the chronic treatment injections when isradipine was given alone. This lack of effect of isradipine treatment showed that the effects of this compound were selective for ethanol withdrawal hyperexcitability. In addition, we have previously shown that isradipine, added to the perfusion medium, did not affect the epileptiform activity produced by the GABA antagonist bicuculline in hippocampal slices from untreated animals (Whittington and Little, 1991fc) .
The prolonged presence of isradipine in the CNS was unexpected, as its hypothermic actions and effects on spontaneous locomotor activity last only 1-2 h in our strain of mice and rapid tolerance to these effects occurred . The dose used, lOmg/kg, was that shown by Supavilai and Karobath (1984) to be required for full displacement in vivo of dihydropyridine binding from rat brain. The decrease in behavioural excitability seen in the present study between 6 and 18 h after the last of the chronic isradipine injections suggested that some residual sedative action could be detected by this test after the chronic treatment. There was a very small increase in behavioural excitability between 24 and 36 h after the last injections of the chronic treatment schedule when isradipine was given alone. The latter result suggests that there may be a minor degree of withdrawal hyperexcitability after this chronic treatment, although this was seen over a time at which the central concentrations of isradipine were quite high.
We have demonstrated that tolerance occurs to the sedative, ataxic and hypothermic actions of isradipine after chronic administration after the 2 week treatment schedule used in the present work . This suggests that the mechanisms involved in the prevention of withdrawal hyperexcitability by isradipine may not be related to those causing sedation, ataxia or hyperthermia. Tolerance does not appear to occur to the cardiovascular actions of isradipine (Pedersen et al., 1989) .
In conclusion, therefore, the decreases in thresholds for elicitation of population spikes in isolated hippocampal slices appear to correlate with withdrawal hyperexcitability, but the transient increases in paired pulse potentiation reported previously may not be important in the behaviour that was measured during the withdrawal syndrome.
